169P Neoadjuvant pembrolizumab + chemotherapy followed by adjuvant pembrolizumab for treatment of high-risk, early-stage triple-negative breast cancer: A network meta-analysis

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 33; pp. S615 - S616
Main Authors Cortés, J., Haiderali, A., Huang, M., Pan, W., Fox, G.E., Park, J., Frederickson, A.M., Fasching, P.A., O'Shaughnessy, J.
Format Journal Article
LanguageEnglish
Published 01.09.2022
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.204